Penserra Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12K | Sell |
30
-390
| -93% | -$156K | ﹤0.01% | 814 |
|
|
2025
Q1 | $208K | Sell |
420
-996
| -70% | -$493K | ﹤0.01% | 733 |
|
|
2024
Q4 | $735K | Buy |
1,416
+984
| +228% | +$511K | 0.01% | 491 |
|
|
2024
Q3 | $266K | Buy |
432
+131
| +44% | +$80.7K | 0.01% | 663 |
|
|
2024
Q2 | $167K | Buy |
301
+271
| +903% | +$150K | ﹤0.01% | 758 |
|
|
2024
Q1 | $17K | Sell |
30
-1,757
| -98% | -$996K | ﹤0.01% | 908 |
|
|
2023
Q4 | $947K | Sell |
1,787
-818
| -31% | -$433K | 0.02% | 389 |
|
|
2023
Q3 | $1.32M | Sell |
2,605
-382
| -13% | -$193K | 0.03% | 311 |
|
|
2023
Q2 | $1.56M | Buy |
2,987
+2,497
| +510% | +$1.3M | 0.03% | 324 |
|
|
2023
Q1 | $281K | Sell |
490
-52
| -10% | -$29.8K | 0.01% | 624 |
|
|
2022
Q4 | $298K | Buy |
542
+100
| +23% | +$55K | 0.01% | 609 |
|
|
2022
Q3 | $224K | Buy |
442
+366
| +482% | +$185K | 0.01% | 613 |
|
|
2022
Q2 | $41K | Sell |
76
-84
| -53% | -$45.3K | ﹤0.01% | 948 |
|
|
2022
Q1 | $93K | Buy |
160
+94
| +142% | +$54.6K | ﹤0.01% | 862 |
|
|
2021
Q4 | $44K | Sell |
66
-6
| -8% | -$4K | ﹤0.01% | 1054 |
|
|
2021
Q3 | $41K | Buy |
72
+2
| +3% | +$1.14K | ﹤0.01% | 1104 |
|
|
2021
Q2 | $35K | Buy |
+70
| New | +$35K | ﹤0.01% | 1074 |
|
|
2020
Q4 | – | Sell |
-8,607
| Closed | -$3.8M | – | 1126 |
|
|
2020
Q3 | $3.8M | Buy |
+8,607
| New | +$3.8M | 0.14% | 147 |
|
|
2019
Q3 | – | Sell |
-102
| Closed | -$29K | – | 959 |
|
|
2019
Q2 | $29K | Sell |
102
-38
| -27% | -$10.8K | ﹤0.01% | 751 |
|
|
2019
Q1 | $38K | Sell |
140
-7,469
| -98% | -$2.03M | ﹤0.01% | 579 |
|
|
2018
Q4 | $1.7M | Buy |
7,609
+5,309
| +231% | +$1.19M | 0.17% | 101 |
|
|
2018
Q3 | $561K | Buy |
2,300
+325
| +16% | +$79.3K | 0.03% | 263 |
|
|
2018
Q2 | $409K | Buy |
1,975
+75
| +4% | +$15.5K | 0.03% | 237 |
|
|
2018
Q1 | $392K | Buy |
1,900
+150
| +9% | +$30.9K | 0.04% | 188 |
|
|
2017
Q4 | $332K | Buy |
1,750
+275
| +19% | +$52.2K | 0.04% | 166 |
|
|
2017
Q3 | $282K | Buy |
1,475
+175
| +13% | +$33.5K | 0.07% | 148 |
|
|
2017
Q2 | $226K | Buy |
1,300
+150
| +13% | +$26.1K | 0.08% | 179 |
|
|
2017
Q1 | $176K | Buy |
1,150
+100
| +10% | +$15.3K | 0.02% | 232 |
|
|
2016
Q4 | $148K | Buy |
1,050
+186
| +22% | +$26.2K | 0.02% | 269 |
|
|
2016
Q3 | $137K | Buy |
864
+432
| +100% | +$68.5K | 0.02% | 212 |
|
|
2016
Q2 | $64K | Buy |
432
+144
| +50% | +$21.3K | 0.01% | 268 |
|
|
2016
Q1 | $40 | Buy |
288
+46
| +19% | +$6 | ﹤0.01% | 312 |
|
|
2015
Q4 | $34K | Buy |
+242
| New | +$34K | ﹤0.01% | 302 |
|